Loss of p27Kip1 but not p21Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis

EMBO Journal

Volumn 21, Issue 14, 2002, Pages 3739-3748

  Martins, Carla P ^a   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CDK2; Lymphomagenesis; MYC; P21Cip1; P27Kip1

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; MYC PROTEIN; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T CELL LYMPHOMA; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA PRIMERS; GENES, MYC; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MICE; PROTEIN-SERINE-THREONINE KINASES; RETROVIRIDAE; SPLEEN; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MURINAE;

EID: 0037099496     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf364     Document Type: Article

References (55)

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
2. Kip1
3. Kip1-independent cell cycle regulation by MYC
4. 1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
5. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
6. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
7. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
8. Increased proteasome, degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
9. Kip1-deficient cells
10. Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region
11. c-Myc target genes involved in cell growth, apoptosis and metabolism
12. 1 checkpoint control
13. KIP1 cooperate in prostate cancer tumor suppression in the mouse
14. 1 arrest
15. Deconstructing myc
16. Kip1-deficient mice
17. Kip1 is haplo-insufficient for tumour suppression
18. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis
19. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15
20. The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2
21. c-Myc enhances protein synthesis and cell size during B lymphocyte development
22. Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: Tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal
23. Retroviral insertional mutagenesis as a strategy to identify cancer genes
24. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas
25. Kipl
26. Simplified mammalian DNA isolation procedure
27. The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice
28. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage
29. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway
30. Kip1 regulates T cell proliferation
31. Lymphoproliferative syndrome associated with cmyc expression driven by a class I gene promoter in transgenic mice
32. Principles of CDK regulation
33. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
34. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors
35. Making decisions through Myc
36. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
37. Myc-enhanced expression of Cull promotes ubiquitin-dependent proteolysis and cell cycle progression
38. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators and Cip and INK4 inhibitors
39. Cip1
40. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
41. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
42. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mace
43. Involvement of c-myc in MuLV-induced T cell lymphomas in mice: Frequency and mechanisms of activation
44. The Pezcoller lecture: Cancer cell cycles revisited
45. 1-phase progression
46. Identification of a novel gene, Vin-1, in murine leukemia virus-induced T-cell leukemias by provirus insertional mutagenesis
47. The integration sites of endogenous and exogenous Moloney murine leukemia virus
48. N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas
49. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors
50. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
51. Mice bearing the Eμ-myc and Eμ-pim-1 transgenes develop pre-B-cell leukemia prenatally
52. Kip1 is abrogated by c-Myc
53. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc
54. Kip1 in acute myeloid leukemia
55. Kip1